Home › Dermatomyositis › Colorado
Dermatomyositis clinical trials in Colorado
4 studies for Dermatomyositis are looking for participants at sites in Colorado.
Cities in Colorado
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Aurora
- Research Site, Denver
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 24, 2026 · NCT06455449RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Children's Hospital Colorado - Accepting Juvenile Patients, Aurora
RecruitingPhase 2/3
Ages 6 to 75 · All sexes · Updated Sep 17, 2026 · NCT06154252A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- University of Colorado Denver, Aurora
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
- University of Colorado, Denver, Denver
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 11, 2026 · NCT07403188From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.